The activation of the oxytocin receptor pathway by means of infusion of oxytocin, oxytocin analogs, or oxytocin agonists may additionally constitute a promising approach for the control of obesity and associated metabolic illnesses in addition to diabetes and its complications. The gene discussed is OXTR; the disease is obesity disorder.